Literature DB >> 1698821

High level transcription of the glucocerebrosidase pseudogene in normal subjects and patients with Gaucher disease.

J Sorge1, E Gross, C West, E Beutler.   

Abstract

Gaucher disease is due to mutations involving the glucocerebrosidase gene. A closely homologous pseudogene is located approximately 16 kD downstream from the functional gene. Sequence analysis of clones from cDNA libraries made from skin fibroblast cultures showed several independent clones with the sequence of an aberrantly processed pseudogene message. Examination of cellular RNA from lymphoblasts or fibroblasts obtained from thirteen Gaucher disease patients, one Gaucher disease heterozygote, and four normal subjects showed that the pseudogene was consistently transcribed, and that in some cases the level of transcription seemed to be approximately equal to that of the functional gene. The transcription of the pseudogene must be taken into account when attempting to detect mutations of glucocerebrosidase by the study of cDNA libraries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698821      PMCID: PMC296842          DOI: 10.1172/JCI114818

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Differential expression of the human glucocerebrosidase-coding gene.

Authors:  O Reiner; M Horowitz
Journal:  Gene       Date:  1988-12-20       Impact factor: 3.688

2.  Leukocyte adhesion deficiency. Aberrant splicing of a conserved integrin sequence causes a moderate deficiency phenotype.

Authors:  T K Kishimoto; K O'Conner; T A Springer
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

3.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.

Authors:  S C Kogan; M Doherty; J Gitschier
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

4.  Human acid beta-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts.

Authors:  P N Graves; G A Grabowski; M D Ludman; P Palese; F I Smith
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

5.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY).

Authors:  M Becker-André; K Hahlbrock
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

6.  Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.

Authors:  B Theophilus; T Latham; G A Grabowski; F I Smith
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

7.  Prediction of severity of Gaucher's disease by identification of mutations at DNA level.

Authors:  A Zimran; J Sorge; E Gross; M Kubitz; C West; E Beutler
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

8.  The human glucocerebrosidase gene has two functional ATG initiator codons.

Authors:  J A Sorge; C West; W Kuhl; L Treger; E Beutler
Journal:  Am J Hum Genet       Date:  1987-12       Impact factor: 11.025

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Quantitation of mRNA by the polymerase chain reaction.

Authors:  A M Wang; M V Doyle; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  15 in total

Review 1.  The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.

Authors:  Arash Velayati; W Haung Yu; Ellen Sidransky
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 2.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.

Authors:  M E Grace; R J Desnick; G M Pastores
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Is esterase-P encoded by a cryptic pseudogene in Drosophila melanogaster?

Authors:  E S Balakirev; F J Ayala
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

6.  Sequence variability of a human pseudogene.

Authors:  R Martínez-Arias; F Calafell; E Mateu; D Comas; A Andrés; J Bertranpetit
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

7.  Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Futwan Al-Mohanna; Nadir R Farid; Brian Meyer; Yufei Shi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

8.  Achondroplasia is defined by recurrent G380R mutations of FGFR3.

Authors:  G A Bellus; T W Hefferon; R I Ortiz de Luna; J T Hecht; W A Horton; M Machado; I Kaitila; I McIntosh; C A Francomano
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

9.  DNA polymorphism in the beta-Esterase gene cluster of Drosophila melanogaster.

Authors:  Evgeniy S Balakirev; V R Chechetkin; V V Lobzin; Francisco J Ayala
Journal:  Genetics       Date:  2003-06       Impact factor: 4.562

10.  Assessing the genomic evidence for conserved transcribed pseudogenes under selection.

Authors:  Amit N Khachane; Paul M Harrison
Journal:  BMC Genomics       Date:  2009-09-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.